S. Grant

发表

R. Heel, S. Grant, 2012, Drugs.

Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.

S. Clissold, S. Grant, Stephen P. Clissold, 1989, Drugs.

Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses.

S. Clissold, S. Grant, Stephen P. Clissold, 1990, Drugs.

Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia.

A. Fitton, S. Grant, A. Fitton, 1994, Drugs.

Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders.

K. Goa, A. Fitton, E. Sorkin, 1990, Drugs.

Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures.

K. Goa, S. Grant, 1992, Drugs.

Erratum to A Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Use in Asthma and Allergic Disorders

K. Goa, A. Fitton, E. Sorkin, 1991, Drugs.

Erratum to A Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Potential in Superficial and Systemic Mycoses

S. Clissold, S. Grant, 2012, Drugs.

Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF)

R. Heel, S. Grant, 1992, Drugs.

Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.

K. Goa, D. McTavish, E. Sorkin, 1990, Drugs.

Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

R. N. Brogden, S. Grant, H. Langtry, 1989, Drugs.

Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders.

D. Faulds, S. Grant, 1992, Drugs.

Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.

K. Goa, S. Grant, H. Langtry, 1989, Drugs.

Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF). A review of its pharmacological properties and prospective role in the management of myelosuppression.

R. Heel, S. Grant, 1992, Drugs.

A Review of its Pharmacology and Therapeutic Potential in the Treatment of Schizophrenia

A. Fitton, S. Grant, 2022 .

Erratum to A Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Use in Asthma and Allergic Disorders

K. Goa, A. Fitton, E. Sorkin, 1991, Drugs.

K. Goa, S. Grant, H. Langtry, 1989, Drugs.

Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders.

D. Faulds, S. Grant, 1992, Drugs.

Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF). A review of its pharmacological properties and prospective role in the management of myelosuppression.

R. Heel, S. Grant, 1992, Drugs.

Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.

K. Goa, D. McTavish, E. Sorkin, 1990, Drugs.

S. Clissold, S. Grant, 2012, Drugs.